Table 3.
Brain ECM | Constituents | NDD | Spatio‐Temporal Dynamics in NDDs | Reference |
---|---|---|---|---|
Interstitial Matrix & PNN |
HA | AD | ↑ at the perimeter of plaques | [189] |
MS |
↑ High‐MW HA accumulation in chronic lesions ↑ Low‐MW HA in acute lesions |
[183, 190] | ||
Proteoglycans | AD | CSPGs present in neurofibrillary tangles and senile plaquesDSPGs associated with senile plaquesKSPGs located at synapses and neurites within plaquesDecorin associated with periphery of plaques and neurofibrillary tanglesHSPG
|
[174, 191, 192, 193] | |
PD | HSPG
|
[194, 195] | ||
MS |
Aggrecan, versican, neurocan, dermatan sulfate proteoglycans ↑ around lesions Aggrecan, versican, neurocan, dermatan sulfate proteoglycans ↓ in the center of lesions |
[196] | ||
Glycoproteins | AD |
Reelin ↓ Tenascin C associated with cored plaques Tenascin C & R significantly ↑ in CSF of female patients Thrombospondin‐1 ↓ |
[197, 198, 199, 200] | |
MS | Tenascin C & R
|
[174, 201] | ||
Basement Membrane |
Collagen | AD |
Collagen IV ↑ Collagen IV ↓ in AD neuropathological change |
[178, 184, 202] |
ALS | Collagen IV ↑ | [203] | ||
PD |
Collagen I expression ↑ Collagen IV ↑ |
[195, 204] | ||
Fibronectin | AD | ↑ | [184, 205] | |
Proteoglycans | AD |
HSPGs ↑ Perlecan ↑ |
[184, 206] | |
Glycoproteins | AD | Laminin
|
[184, 202, 205, 207, 208, 209, 210, 211] | |
ALS | Laminin ↑ | [212, 213] |